APP and Alzheimer disease: Although AD is considered to begin as a synaptopathy, it is not yet understood how the segregation of APP and secretases at nanoscale contributes toward the progression of AD (De Strooper and Karran, 2016; Haass et al., 2012; Selkoe et al., 2012; Selkoe, 2002).